Rankings
▼
Calendar
COLL Q1 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$16M
Net Income
-$16M
EPS (Diluted)
$-0.68
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$136M
Total Liabilities
$15M
Stockholders' Equity
$122M
Cash & Equivalents
$135M
← FY 2016
All Quarters
Q2 2016 →
